NCT00983047 2015-08-27Nimotuzumab Plus Docetaxel in Chemotherapy-Refractory/Resistant Patients With Advanced Non-Small-Cell Lung CancerBiotech Pharmaceutical Co., Ltd.Phase 2 Terminated30 enrolled